- Decision follows recommendation of Independent Data Monitoring Committee -

Astellas Americas President Jim Robinson to discuss the importance of listening to patients in tackling health decision-making, financial burden and transparency in care

Long recognized for her impact in marketing and communications throughout the biopharma industry.

- Acquisition Expands Astellas' Late Stage Clinical Pipeline with Fezolinetant -

Astellas ranked 25th on list for its commitment to changing tomorrow for patients and communities

Astellas Americas Names Catherine Levitt Regional General Counsel for the Americas

Builds on Company Commitment to improve Access to Health